Northwest Biotherapeutics reported $1.05M in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agenus AGEN:US USD 2.95M 120K
Applied Genetic Technologies AGTC:US USD 68K 17K
AstraZeneca AZN:LN USD 387M 0
Bristol Myers Squibb BMY:US USD 292M 0
Celldex Therapeutics CLDX:US USD 47K 0
Cti Biopharma CTIC:US USD 127K 13K
Cytori Therapeutics CYTX:US USD 32K 10K
Cytrx CYTR:US USD 43.48K 4.7K
Eisai 4523:JP JPY 44.99B 0
Genocea Biosciences GNCA:US USD 59K 1000
Infinity Pharmaceuticals INFI:US USD 89K 0
Mirati Therapeutics MRTX:US USD 58K 2K
Northwest Biotherapeutics NWBO:US USD 1.05M 17K